Sagimet Biosciences
SGMT
SGMT
51 hedge funds and large institutions have $76.2M invested in Sagimet Biosciences in 2023 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 9 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
5.26% less ownership
Funds ownership: 72.88% → 67.62% (-5.3%)
41% less capital invested
Capital invested by funds: $130M → $76.2M (-$54M)
Holders
51
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$3.48M | |
| 2 | +$1.93M | |
| 3 | +$1.34M | |
| 4 |
BlackRock
New York
|
+$347K |
| 5 |
State Street
Boston,
Massachusetts
|
+$271K |
Top Sellers
| 1 | -$4.53M | |
| 2 | -$4.07M | |
| 3 | -$3.52M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.74M |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$1.48M |